- Report
- August 2025
- 197 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 197 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 144 Pages
Global
From €2760EUR$3,160USD£2,397GBP
€3450EUR$3,950USD£2,997GBP
- Report
- June 2025
- 85 Pages
Global
From €8729EUR$9,995USD£7,583GBP
- Report
- April 2024
- 115 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- January 2022
- 200 Pages
Global
From €6550EUR$7,500USD£5,690GBP
- Report
- September 2025
- 50 Pages
Global
From €2314EUR$2,650USD£2,010GBP
Prednisolone is a corticosteroid drug used to treat a variety of immune disorders, including asthma, allergies, and autoimmune diseases. It works by reducing inflammation and suppressing the immune system. Prednisolone is available in both oral and injectable forms, and is often prescribed in combination with other drugs. It is generally well-tolerated, but can cause side effects such as weight gain, increased appetite, and mood swings.
Prednisolone is a widely used drug in the treatment of immune disorders, and is available from a variety of pharmaceutical companies. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more